Scrip AMR Round Table Part 4: Pipeline Progress But Education Needs Work
Executive Summary
In a round table discussion held on the sidelines of the ECCMID conference in Amsterdam in April 2016, a panel of experts offered their perspectives on the problem of antimicrobial resistance, and what it will take to protect the world's population from this threat.
In Part 4, the panelists speak about the R&D pipeline and about the challenges of educating doctors and patients on antibiotic stewardship.
The round table was chaired by Scrip Editor Eleanor Malone, and the panelists were:
- John Rex, Senior Vice-President and Chief Strategy Officer for AstraZeneca's antibiotics business unit.
- Professor Mike Sharland, Professor of Paediatric Infectious Disease at St George's University Hospital and Chair of a government Expert Advisory Committee on AMR for England.
- Roman Kozlov, Chief Specialist at the Ministry of Health of the Russian Federation in Clinical Microbiology and Antimicrobial Resistance, and a Director at the Institute of Antimicrobial Chemotherapy at the Smolensk State Medical University.
- Matteo Bassetti, head of Infectious Diseases Division of the Santa Maria Misericordia University Hospital in Udine, Italy, and Professor of Infectious Diseases at the School of Medicine and Postgraduate School of Infectious Diseases at the University of Udine.
This Round Table was hosted by Scrip with sponsorship from AstraZeneca.